ZVRA Earnings
Latest Revenue39.7M
Latest Net Income8.8M
| Period | EPS | Revenue | Net Income | Rev YoY | EPS YoY |
|---|
| Q2 2026 | $0.14 | 39.7M | 8.8M | +16.2% | -36.4% |
| Q2 2026 | $0.14 | 39.7M | 8.8M | +16.2% | -36.4% |
| Q1 2026 | $0.62 | 36.2M | 37.9M | +39.0% | +6,300.0% |
| Q1 2026 | $0.62 | 36.2M | 37.9M | +39.0% | +6,300.0% |
| Q4 2025 | $0.22 | 34.1M | 12.2M | +31.9% | -82.3% |
| Q4 2025 | $0.22 | 34.1M | 12.2M | +31.9% | -82.3% |
| Q3 2025 | -$0.01 | 26.1M | -544000 | +27.8% | +83.3% |
| Q3 2025 | -$0.01 | 26.1M | -544000 | +27.8% | +83.3% |
| Q2 2025 | $1.24 | 25.9M | 74.7M | — | — |
| Q2 2025 | $1.24 | 25.9M | 74.7M | — | — |
| Q1 2025 | -$0.06 | 20.4M | -3099000 | — | — |
| Q1 2025 | -$0.06 | 20.4M | -3099000 | — | — |
Zevra Therapeutics (ZVRA) — Earnings